Диссертация (1139881), страница 13
Текст из файла (страница 13)
Interventions topromote physical activity and dietary lifestyle changes for cardiovascular riskfactor reduction in adults: a scientific statement from the American HeartAssociation // Circulation, 2010, No. 122, pp. 406–441.22.Badimon L, Hernandez Vera R, Vilahur G. Atherothrombotic risk inobesity // Hamostaseologie, 2013, No. 33, pp.
259–268.23.Baglin T, Gray E, Greaves M et al. British Committee for Standardsin Haematology. Clinical guidelines for testing for heritable thrombophilia // Br JHaematol, 2010, Vol. 149, No. 2, pp. 209-20.24.Bank I, Scavenius MP, Buller HR, Middeldorp S. Social aspects ofgenetic testing for factor V Leiden mutation in healthy individuals and theirimportance for daily practice // Thromb Res, 2004, No. 113, pp. 7-12.25.Barbar S, Noventa F, Rossetto V, et al. A risk assessment model forthe identification of hospitalized medical patients at risk for venous107thromboembolism: the Padua Prediction Score // J Thromb Haemost, 2010, Vol.8, No. 11, pp. 2450-7.26.Barcellona D, Fenu L, Cauli C, Pisu G, Marongiu F.
Allele 4G ofgene PAI-1 associated with prothrombin mutation G20210A increases the risk forvenous thrombosis // Thromb Haemost, 2003, Vol. 90, No. 6, pp. 1061-4.27.Barker-Collo S, Bennett DA, Krishnamurthi RV, Parmar P, FeiginVL, Naghavi M, Forouzanfar MH, Johnson CO, Nguyen G, Mensah GA, Vos T,Murray CJ, Roth GA; GBD 2013 Writing Group; GBD 2013 Stroke PanelExperts Group. Sex differences in stroke incidence, prevalence, mortality anddisability-adjusted life years: results from the Global Burden of Disease Study2013 // Neuroepidemiology, 2015, No. 45, pp. 203–214.28.Baroletti S, Munz K, Sonis J, et al.
Electronic alerts for hospitalisedhigh-VTE risk patients not receiving prophylaxis: a cohort study // J ThrombThrombol , 2008, No. 25, pp. 146–150.29.Bauer KA. Management of thrombophilia // J Thromb Haemost,2003, Vol. 1, No. 7, pp. 1429-34.30.Beckert L, Rahman A. Pneumonia and venous thromboembolism: Isthe evidence catching up with the guidelines? // Respirology, 2015, Vol.20, No.5, pp. 695-6.31.Bernstein AM, de Koning L, Flint AJ, Rexrode KM, Willett WC.Soda consumption and the risk of stroke in men and women // Am J Clin Nutr,2012, No.
95, pp. 1190–1199.32.Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR. No associationbetween the common MTHFR 677C->T polymorphism and venous thrombosis:results from the MEGA study // Arch Intern Med, 2007, No. 167, pp. 497–501.33.Bezemer ID, van der Meer FJ, Eikenboom JC, Rosendaal FR,Doggen CJ. The value of family history as a risk indicator for venous thrombosis// Arch Intern Med, 2009, No. 169, pp. 610–615.10834.Bloom DE, Cafiero ET, Jane´-Llopis E et al. World EconomicForum // The Global Economic Burden of Non-communicable Diseases. Geneva,Switzerland. 2011.35.Bounameaux H. ISTH EDUCATIONAL COURSE. Thrombosis andhemorrhage. What are the causes? // Risk factors and pathogenesis of thrombosis.Россия, г. Санкт-Петербург.
2017.36.Brecker SJ, Stevenson RN, Roberts R, Uthayakumar S, Timmis AD,Balcon R. Acute myocardial infarction in patients with normal coronary arteries //BMJ, 1993, No. 307, pp. 1255–1256.37.Bucciarelli P, De Stefano V, Passamonti SM, Tormene D, LegnaniC, Rossi E, Castaman G, Simioni P, Cini M, Martinelli I. Influence of proband'scharacteristics on the risk for venous thromboembolism in relatives with factor VLeiden or prothrombin G20210A polymorphisms // Blood, 2013, Vol. 122, No.15, pp. 2555-61.38.Burzotta F, Paciaroni K, De Stefano V, Crea F, Maseri A, Leone G,Andreotti F. G20210A Prothrombin gene polymorphism and coronary ischaemicsyndromes: a phenotype-specific meta-analysis of 12 034 subjects // Heart, 2004,Vol.90, No. 1, pp.
82–86.39.Bybee KA, Kara T, Prasad A, Lerman A, BarsnessGW, Wright RS,Rihal CS. Systematic review: transient left ventricular apical ballooning: asyndrome that mimics ST-segment elevation myocardial infarction // Ann IntMed, 2004, No. 141, pp. 858–865.40.Camden R, Ludwig S. Prophylaxis against venous thromboembolismin hospitalized medically ill patients: Update and practical approach // Am JHealth Syst Pharm, 2014, Vol.
71, No. 11, pp. 909-17.41.Cannegieter SC, Doggen CJ, van Houwelingen HC, Rosendaal FR.Travel-related venous thrombosis: results from a large population-based casecontrol study (MEGA study) // PLoS Med, 2006, Vol. 3, No. 8, P. e307.42.Chen YG, Lin TY, Huang WY, Lin CL, Dai MS, Kao CH.Association between pneumococcal pneumonia and venous thromboembolism in109hospitalized patients: a nationwide-population based study // Respirology, 2015,No. 20, pp. 799–804.43.Chobanian AV, Bakris GL, Black HR, et al; Joint NationalCommittee on Prevention, Detection, Evaluation, and Treatment of High BloodPressure. National Heart, Lung, and Blood Institute; National High BloodPressure Education Program Coordinating Committee.
Seventh report of the JointNational Committee on Prevention, Detection, Evaluation, and Treatment of HighBlood Pressure // Hypertension, 2003, No. 42, pp. 1206–1252.44.Chopra V, Anand S, Hickner A, Buist M, Rogers MA, Saint S,Flanders SA. Risk of venous thromboembolism associated with peripherallyinserted central catheters: a systematic review and meta-analysis // Lancet, 2013,Vol. 382, No. 9889, pp. 311-25.45.Chow CK, Islam S, Bautista L, et al. Parental history and myocardialinfarction risk across the world: the INTERHEART Study // J Am Coll Cardiol,2011, Vol. 57, pp.
619–627.46.Christiansen SC, Lijfering WM, Helmerhorst FM, Rosendaal FR,Cannegieter SC. Sex difference in risk of recurrent venous thrombosis and therisk profile for a second eventJ // J Thromb Haemost, 2010, No. 8, pp. 21592168.47.CohenAT,AgnelliG,AndersonFA,etal.Venousthromboembolism (VTE) in Europe // Thromb Haemost, 2007, No.
98, pp. 756764.48.Cohn DM, Vansenne F, Kaptein AA, de Borgie CA, Middeldorp S.The psychological impact of testing for thrombophilia: a systematic review // JThromb Haemost, 2008, No. 6, pp. 1099–104.49.Coppens M, Reijnders JH, Middeldorp S, Doggen CJ, Rosendaal FR.Testing for inherited thrombophilia does not reduce the recurrence of venousthrombosis // J Thromb Haemost, 2008, Vol. 6, No. 9, pp. 1474-7.50.Cushman M. Epidemiology and Risk Factors for Venous Thrombosis// Semin Hematol, 2007, Vol. 44, No. 2, pp. 62–69.11051.Da Costa A, Isaaz K, Faure E, Mourot S, Cerisier A, Lamaud M.Clinical characteristics, aetiological factors and long-term prognosis ofmyocardial infarction with an absolutely normal coronary angiogram: A 3-yearfollow-up study of 91 patients // European Heart Journal, 2001, No.
22, pp. 14591465.52.Da Costa A, Tardy B, Haouchette K, Mismetti P, Cerisier A, LamaudM, Guyotat D, Isaaz K. Long term prognosis of patients with myocardialinfarction and normal coronary angiography: Impact of inherited coagulationdisorders // Thrombosis and Haemostasis, 2004, No. 91, pp. 388-393.53.Da Costa A, Tardy-Poncet B, Isaaz K, Cerisier A, Mismetti P,Simitsidis S, Reynaud J, Tardy B, Piot M, Decousus H, Guyotat D. Prevalence offactor v leiden (apcr) and other inherited thrombophilias in young patients withmyocardial infarction and normal coronary arteries // Heart, 1998, No.
80, pp.338-340.54.Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes ofdeath in the United States: comparative risk assessment of dietary, lifestyle, andmetabolic risk factors // PLoS Med, 2009, Vol. 6, e1000058.55.Darvall KAL, Sam RC, Silverman SH, Bradbury AW, Adam DJ.Obesity and Thrombosis // Eur J Vasc Endovasc Surg, 2007, Vol. 33, No. 2, pp.223-233.56.Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR andrisk of venous thrombosis: a meta-analysis of published epidemiological studies //J Thromb Haemost, 2005, No.
3, pp. 292–9.57.Douketis J, Tosetto A, Marcucci M et al. Risk of recurrence aftervenous thromboembolism in men and women: patient level meta-analysis // BMJ,2011, No. 342, P. d813.58.Eastern Stroke and Coronary Heart Disease Collaborative ResearchGroup. Blood pressure, cholesterol, and stroke in eastern Asia // Lancet, 1998,No. 352, pp. 1801–1807.11159.Eekhoff EM, Rosendaal FR, Vandenbroucke JP.
Minor events andthe risk of deep venous thrombosis // Thromb Haemost, 2000, No. 83, pp. 408411.60.Emelia J. Benjamin, Michael J. Blaha et al. Heart Disease and StrokeStatistics—2017 Update: A Report from the American Heart Association //Circulation, 2017, No. CIR.0000000000000485.61.Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global Burdenof Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBDStroke Experts Group. Global and regional burden of stroke during 1990-2010:findings from the Global Burden of Disease Study 2010 // Lancet, 2014, No.
383,pp. 245–254.62.Feigin VL, Krishnamurthi RV, Parmar P, et al; GBD 2013 WritingGroup; GBD 2013 Stroke Panel Experts Group. Update on the global burden ofischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 Study //Neuroepidemiology, 2015, No. 45, pp. 161–176.63.Finkelstein EA, Khavjou OA, Thompson H et al. Obesity and severeobesity forecasts through 2030 // Am J Prev Med, 2012, Vol. 42, No.
6, pp. 56370.64.Foy P, Moll S. Thrombophilia: 2009 update // Curr Treat OptionsCardiovasc Med, 2009, Vol. 11, No. 2, pp. 114-28.65.Garcia-Horton A, Kovacs MJ, Abdulrehman J, Taylor JE, Sharma S,Lazo-LangnerA.Impactofthrombophiliascreeningonvenousthromboembolism management practices // Thromb Res, 2017, No.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
